AI-assisted, human-published
01/16/2024 /Funding Events
Granata Bio Secures $14M Series A Funding Led by GV to Revolutionize Infertility Medication Market
Boston-based Granata Bio, Inc. closes a $14M Series A funding round to address unmet needs in women's health and develop a portfolio of four medications catering to infertility and IVF. SOURCE
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com